The European Union is unlikely to order more AstraZeneca vaccines, despite the continent’s slow adoption, after data showed that blood clots are very rare, said a senior French politician.
Although no decision has been confirmed, French Industry Minister Agnes Pannier-Runacher said today that “it is very likely” that no more cans will be ordered.
This is despite the statement by the European Medicines Agency and the World Health Organization that the benefits of the vaccine far outweigh the risks.
The EU is also unlikely to order more doses of the unique Johnson and Johnson vaccine, Ms. Pannier-Runacher said after data showed that it can cause clots too.
European leaders have been heavily criticized for being overly cautious with vaccines as the EU leads one of the slowest vaccination programs in the world, despite the rise in Covid cases across the continent and lockdowns tightening.
In Germany today, Angela Merkel is calling on MPs to pass emergency laws that automatically provide for bans for regions where Covid cases exceed a certain level – bypassing the authority of the regional governors who opposed them.
The EU’s jab roll-out continues to lag behind other large countries after being hit by bureaucracy, bureaucracy and political interference
The EU is unlikely to order more doses of AstraZeneca or Johnson & Johnson Covid vaccines after blood clots were listed as a very rare side effect of both shocks (file image).
“The situation is serious, very serious, and we have to take it seriously,” she told lawmakers.
‘There is no way around. We have to stop this third wave of the pandemic … and to achieve this, we have to combine the strengths of the federal, state and local levels better than before. ‘
Critics argue that if Germany’s vaccine campaign had kept pace with Britain, which has relied largely on AstraZeneca’s vaccine to protect more than half of its adult population, the lockdown would not be necessary at all, and easing measures.
Merkel – who is believed to be getting the AstraZenica bump herself today – admitted in her speech that the new powers are not a bulletproof solution to the pandemic that can only be defeated with vaccinations.
The introduction of Europe has been plagued by red tape, red tape and interference, with EU countries temporarily banning the use of AstraZeneca bumps due to fear of blood clots.
While most nations have now resumed the use of the sting, it has fallen out of favor and is largely restricted to older age groups.
Denmark became the first European country to announce yesterday that it will not use AstraZeneca shocks as part of its launch.
This despite the fact that medical professionals point out that the risk of getting blood clots from Covid infection is eight times higher than from the vaccine.
Ms. Pannier-Runacher said on French radio on Friday: “We have not started any discussions with Johnson & Johnson or AstraZeneca about a new contract.
“But we have started talks with Pfizer / BioNTech and Moderna.”
Angela Merkel is trying today to convince MPs to pass new lockdown laws in Germany that would automatically put areas into restrictions if Covid cases increase
Germany is battling a resurgent third wave of Covid after slow adoption of vaccines left people vulnerable to infection
Deaths from the virus, which have been falling since the beginning of January, are now picking up again and are calling for stricter lockdown measures
The EU currently has a deal with AstraZeneca for 300 million doses of its vaccine, of which only about 30 million have so far been given due to production problems that sparked an all-powerful dispute back in January.
Meanwhile, Johnson & Johnson is slated to ship 200 million doses to the EU this year, but has delayed its launch in Europe after the American Centers for Disease Control linked it to a very rare risk of blood clots, which too can be observed in the Astra stitch.
An internal EU memo therefore states that these contracts are unlikely to be renewed at the end of the year, reported the Italian newspaper La Stampa this week.
Instead, the EU is in talks with Pfizer / BioNTech over an additional 1.8 billion doses of their batch.
The company announced that 50 million cans, due to be shipped by the end of the year, will actually be available much sooner – possibly this month.
Earlier this week, EU President Ursula von der Leyen, who was heavily criticized for her handling of the EU’s vaccination strategy, said: “We have to focus on technologies that have proven themselves. mRNA vaccines [such as Pfizer] are a clear example of this. ‘
Despite clot fears, Federal Finance Minister Olaf Scholz said he would receive his first shot of the COVID-19 vaccine from AstraZeneca on Friday.
“I have always said that I would get vaccinated when it was my turn,” the 62-year-old told journalists on Friday. Germany has restricted the use of the vaccine to those over 60.
‘Today is the day. Immediately after [this press conference] I’m going to get a shot of the AstraZeneca vaccine. ‘
French Industry Minister Agnes Pannier-Runacher (left) said the EU was unlikely to order any more AstraZeneca, as Ursula von der Leyen said negotiations with Pfizer were open
According to German media, Chancellor Angela Merkel (66) will also receive the AstraZeneca vaccine on Friday. The law firm declined to confirm the reports.
Von der Leyen, a former minister in Merkel’s government, received a shot of the vaccine from BioNTech and Pfizer on Thursday.
Merkel’s drive for stricter lockdown measures comes when Germany recorded 25,831 new cases of COVID-19 and 247 additional deaths overnight, according to the Robert Koch Institute’s Disease Control Center.
The proposed emergency brake would apply in regions with more than 100 new weekly cases per 100,000 inhabitants.
It would stipulate the implementation of a uniform set of rules imposed by the federal government, which would result in the closure of shops, cultural and sports facilities, the limitation of personal contacts and night curfews.
This is to end the patchwork of measures that shaped the pandemic in the 16 German federal states.
In Germany, lockdown measures are being adopted at the state level, and many have expressed frustration and confusion in recent months when governors interpreted the rules agreed with the federal government differently despite similar infection rates.
Under the law, states would be free to set more flexible rules in regions with fewer than 100 new cases per week per 100,000 inhabitants.
There are currently just over 160 cases per week per 100,000 inhabitants nationwide in Germany.
“Intensive care physicians call for help one after another. Who are we if we leave these calls unheard? ‘Asked Merkel. “We can’t leave the doctors and nurses alone.”
The lower house of parliament is expected to vote on the bill next week, with the upper house to follow.